Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Amedo Ruberto
Changes in BDNF Serum Levels in Patients With Major Depression Disorder (MDD) After 6 Months Treatment With Sertraline, Escitalopram, or Venlafaxine
Journal of Psychiatric Research
Psychiatry
Biological Psychiatry
Mental Health
Related publications
Venlafaxine Versus Sertraline for Major Depressive Disorder
Journal of Clinical Psychiatry
Medicine
Psychiatry
Mental Health
Alterations in Serum BDNF and GDNF Levels After 12 Weeks of Antidepressant Treatment in Female Outpatients With Major Depressive Disorder
Psychiatry Investigation
Psychiatry
Mental Health
Biological Psychiatry
Alterations of Serum Levels of BDNF-Related miRNAs in Patients With Depression
PLoS ONE
Multidisciplinary
Increase in IL-6 Levels Among Major Depressive Disorder Patients After a 6-Week Treatment With Duloxetine 60 Mg/Day: A Preliminary Observation
Neuropsychiatric Disease and Treatment
Psychiatry
Mental Health
Biological Psychiatry
Reduced Serum BDNF Levels Are Associated With the Increased Risk for Developing MDD: A Case–control Study With or Without Antidepressant Therapy
BMC Research Notes
Biochemistry
Medicine
Genetics
Molecular Biology
Decreased Plasma BDNF Levels of Patients With Somatization Disorder
Psychiatry Investigation
Psychiatry
Mental Health
Biological Psychiatry
Symtomatic Factors in Patients With Major Depressive Disorder (MDD): Results From an Observational Study
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Plasma Levels of IL-6 in Patients With Untreated Major Depressive Disorder: Comparison With Catecholamine Metabolites
Neuropsychiatric Disease and Treatment
Prediction of Depression in Schizophrenia: Can Serum Levels of BDNF or EGF Help Us?
African Journal of Psychiatry (South Africa)
Psychiatry
Mental Health